The authors present the case of an extremely premature baby affected by severe Necrotizing Enterocolitis (NEC) needing intestinal resection and ileostomy.
An enteric fistula developed 3 days after ostomy closure. The baby was started on Total Parenteral Nutrition (TPN), and 7 days later the fistula output remained constant. Somatostatin (SM) was then given intravenously (3.0 μg/Kg/hr) and the fistula closed on the 3rd day of treatment.
Since SM was introduced in 1986 as an adjunct treatment to TPN in enteric fistulas, the authors believe that theirs is the first report of a successful SM treatment in a premature.
Get full access to this article
View all access options for this article.
References
1.
Brazeau P., Vale W., Burgos R., et al. "Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone." Science1973;179:77-9.
2.
Saudin F. "La somatostatine, pour quoi faire?." Pediatrie1987;42:339-49.
3.
Di Constanzo J., Cano N., Martin J. "Somatostatin in persistent gastrointestinal fistula treated by total parenteral nutrition." Lancet1982;ii:338-9.
4.
Hild P., Stoyanv M., Dobroschke J., et al. "La somatostatine dans le traitement medical des fistules du pancreas et de l'intestine grêle." Ann Chir1982;36:193-6.
5.
Quintans A., Garcia Sabrido JL, Valdecantos E."La somatostatina en el tratamiento de las fistulas pancreáticas e intestinales ." Cir Esp1986;6: 1225-36.
6.
Nubiola-Calonge P., Sancho J., Segura M., et al. "Evaluación a ciegas del efecto de la octreotida (SMS 201-995), un análogo de la somatostatina, sobre el flujo a través de las fistulas de intestino delgado." Lancet (Ed. Esp)1988;12:120-1.
